Lewes, DE -- (SBWIRE) -- 10/29/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: American Capital Ltd. (NASDAQ:ACAS), Antares Pharma Inc (NASDAQ:ATRS), Century Aluminum Co (NASDAQ:CENX), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)
American Capital Ltd. (NASDAQ:ACAS) opened its shares at the price of $14.21 for the day. Its closing price was $14.15 after losing -0.94% for the day. The company traded with the total volume of 1.09 million shares, while its average trading volume remained 1.92 million shares. The beta of ACAS stands at2.52. American Capital, Ltd. is a private equity and venture capital firm specializing in management and employee buyouts, leveraged finance, mezzanine, acquisition, recapitalization, middle market, and growth capital investments.
Has ACAS Found The Bottom and Ready To Move Up? Find Out Here
Antares Pharma Inc (NASDAQ:ATRS) percentage change plunged -0.48% to close at $4.13 with the total traded volume of 1.09 million shares, and average volume of 2.61 million. The 52 week range of the stock remained $3.35 - $5.15, while its day lowest price was $4.08 and it hit its day highest price at $4.15. Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide.
Has ATRS Found The Bottom And Ready To Gain Momentum? Find Out Here
Century Aluminum Co (NASDAQ:CENX) started its trading session with the price of $1.08 and closed at $9.39 by scoring +3.64%. CENX’s stocks traded with total volume of 1.08 million shares, while the average trading volume remained 1 966,236.00 shares. The beta of CENX stands at 3.44. Day range of the stock was $8.95 -$9.41. Century Aluminum Company, together with its subsidiaries, produces and sells primary aluminum primarily in the United States and Iceland.
For How Long CENX’s Gloss will Attract Investors? Find out via this report
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) ended its day with the loss of -0.55% and closed at the price of $3.60 after opening at $3.62. Stock traded during its last trading session with the total volume of 1.08 million shares, as compared to its average volume of 1.60 million shares. ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the discovery and development of new cancer therapies.
Why Should Investors Buy ZIOP After the Recent Fall? Just Go Here and Find Out
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/